Genesis Healthcare, Inc. (GENN) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
GENN steht fuer Genesis Healthcare, Inc., ein Healthcare-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Bewertet mit 46/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 16. März 2026Genesis Healthcare, Inc. (GENN) Gesundheitswesen & Pipeline-Uebersicht
Genesis Healthcare, Inc. provides skilled nursing and rehabilitation services across the United States, operating a network of facilities and offering specialized medical services. Facing competitive pressures and regulatory changes, the company focuses on delivering inpatient and rehabilitation services to a diverse patient base.
Investmentthese
Genesis Healthcare operates in a challenging environment, reflected in its negative profit margin of -1.5%. The company's gross margin stands at 42.2%. Key value drivers include its extensive network of facilities and the demand for skilled nursing and rehabilitation services. Growth catalysts involve expanding rehabilitation services and optimizing facility operations. Potential risks include regulatory changes, reimbursement pressures, and competition from other healthcare providers. Investors should monitor the company's ability to improve profitability and navigate the evolving healthcare landscape. The company's beta of -1.21 suggests a negative correlation to market movements.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Operates approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020.
- Provides rehabilitation therapy services to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China.
- Profit margin of -1.5% indicates ongoing challenges in achieving profitability.
- Gross margin of 42.2% reflects the company's ability to manage direct costs effectively.
- Employs approximately 44,000 individuals, highlighting its significant role as an employer in the healthcare sector.
Wettbewerber & Vergleichsunternehmen
Staerken
- Extensive network of facilities.
- Comprehensive range of services.
- Established presence in multiple states.
- Experienced management team.
Schwaechen
- Negative profit margin.
- High debt levels.
- Exposure to regulatory changes.
- Dependence on government reimbursement programs.
Katalysatoren
- Ongoing: Expansion of rehabilitation services to new geographic markets and healthcare settings.
- Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
- Ongoing: Technology integration and innovation to improve operational efficiency and patient care.
- Ongoing: Focus on value-based care models to improve patient outcomes and reduce costs.
- Ongoing: Development of specialty programs to cater to specific patient populations and healthcare needs.
Risiken
- Potential: Increasing competition from other healthcare providers.
- Potential: Rising labor costs and staffing shortages.
- Potential: Changes in government reimbursement policies.
- Potential: Economic downturns and reduced consumer spending.
- Ongoing: Regulatory changes and compliance requirements.
Wachstumschancen
- Expansion of Rehabilitation Services: Genesis Healthcare can expand its rehabilitation therapy services to new geographic markets and healthcare settings. The market for rehabilitation services is projected to grow as the population ages and the demand for post-acute care increases. By leveraging its existing infrastructure and expertise, Genesis Healthcare can capture a larger share of this market, potentially increasing revenue by 10-15% over the next three years.
- Strategic Partnerships and Acquisitions: Genesis Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Collaborating with hospitals, physician groups, and other healthcare providers can enhance patient referrals and improve care coordination. Acquiring smaller skilled nursing facilities and assisted living communities can provide access to new markets and patient populations, driving revenue growth and market share gains.
- Technology Integration and Innovation: Investing in technology and innovation can improve operational efficiency, enhance patient care, and reduce costs. Implementing electronic health records (EHRs), telehealth solutions, and remote monitoring devices can streamline workflows, improve communication, and enable more personalized care. These technologies can also help Genesis Healthcare attract and retain patients, improve patient satisfaction, and reduce hospital readmission rates.
- Focus on Value-Based Care: Shifting towards value-based care models can improve patient outcomes, reduce costs, and enhance reimbursement rates. By participating in accountable care organizations (ACOs) and other value-based payment arrangements, Genesis Healthcare can align its incentives with those of payers and providers. This can lead to increased patient referrals, improved care coordination, and higher reimbursement rates, driving revenue growth and profitability.
- Development of Specialty Programs: Genesis Healthcare can develop specialty programs to cater to specific patient populations and healthcare needs. Examples include programs for patients with Alzheimer's disease, Parkinson's disease, and other chronic conditions. By offering specialized care and services, Genesis Healthcare can attract patients with complex medical needs and differentiate itself from competitors. This can lead to increased patient referrals, higher reimbursement rates, and improved patient outcomes.
Chancen
- Expansion of rehabilitation services.
- Strategic partnerships and acquisitions.
- Technology integration and innovation.
- Focus on value-based care.
Risiken
- Increasing competition.
- Rising labor costs.
- Changes in reimbursement policies.
- Economic downturns.
Wettbewerbsvorteile
- Extensive network of skilled nursing and assisted living facilities.
- Established relationships with healthcare providers and payers.
- Comprehensive range of rehabilitation therapy services.
- Experience in providing care to diverse patient populations.
Ueber GENN
Genesis Healthcare, Inc., founded in 2003 and headquartered in Kennett Square, Pennsylvania, is a major provider of skilled nursing and assisted living services in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Its Inpatient Services segment includes a network of approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020. The Rehabilitation Therapy Services segment offers physical therapy, occupational therapy, speech-language pathology, and respiratory therapy. These services are provided to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China. The Other Services segment provides physician, staffing, and other healthcare-related services. Genesis Healthcare was formerly known as FC-GEN Operations Investment, LLC, changing its name in February 2015. The company's focus is on providing comprehensive care and rehabilitation services to patients requiring skilled nursing and assisted living support.
Was das Unternehmen tut
- Owns and operates skilled nursing facilities.
- Operates assisted/senior living facilities.
- Provides inpatient services.
- Offers rehabilitation therapy services (physical, occupational, speech).
- Supplies respiratory therapy services.
- Offers physician staffing services.
- Provides other healthcare-related services.
Geschaeftsmodell
- Generates revenue from inpatient services provided at skilled nursing and assisted living facilities.
- Earns revenue from rehabilitation therapy services offered to patients in various healthcare settings.
- Receives payments from Medicare, Medicaid, and private insurance companies.
- Provides staffing and other healthcare-related services to generate additional revenue.
Branchenkontext
Genesis Healthcare operates within the medical care facilities industry, which is influenced by factors such as an aging population, increasing demand for long-term care services, and evolving regulatory requirements. The industry is competitive, with key players including ACORQ, CHCR, GDBYF, GNBT, and MGFRF. Market trends include a growing emphasis on value-based care, the integration of technology to improve patient outcomes, and the expansion of home-based care services. Genesis Healthcare's position is defined by its extensive network of facilities and its focus on providing comprehensive rehabilitation and skilled nursing services.
Wichtige Kunden
- Individuals requiring skilled nursing care.
- Seniors needing assisted living services.
- Patients requiring rehabilitation therapy.
- Hospitals and healthcare facilities needing rehabilitation and respiratory therapy services.
Finanzdaten
Chart & Info
Genesis Healthcare, Inc. (GENN) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer GENN verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer GENN.
Kursziele
Wall-Street-Kurszielanalyse fuer GENN.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von GENN auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: David Sheridan Harrington
CEO
David Sheridan Harrington serves as the CEO of Genesis Healthcare, overseeing the operations of a large healthcare organization with approximately 44,000 employees. His background includes extensive experience in healthcare management and leadership. He is responsible for setting the strategic direction of the company, managing its financial performance, and ensuring the delivery of high-quality care to patients. Harrington's leadership is focused on driving innovation, improving operational efficiency, and enhancing patient outcomes.
Erfolgsbilanz: Under David Sheridan Harrington's leadership, Genesis Healthcare has focused on navigating the challenges of the healthcare industry, including regulatory changes and reimbursement pressures. Key milestones include efforts to expand rehabilitation services and improve facility operations. His strategic decisions aim to enhance the company's financial performance and ensure the long-term sustainability of its business model.
GENN OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that Genesis Healthcare may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier typically involves higher risks compared to exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure and transparency.
- Higher price volatility due to lower trading volume.
- Potential for fraud or manipulation.
- Lack of regulatory oversight and investor protection.
- Going concern risk due to financial distress.
- Verify the company's financial statements and SEC filings.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and corporate governance practices.
- Review the company's risk factors and legal disclosures.
- Check for any regulatory actions or investigations.
- Monitor the company's news and press releases.
- Consult with a financial advisor before investing.
- Established history of operations in the healthcare sector.
- Presence of experienced management team.
- Network of skilled nursing and assisted living facilities.
- Provision of essential healthcare services.
- Compliance with regulatory requirements.
Haeufige Fragen zu GENN
What are the key factors to evaluate for GENN?
Genesis Healthcare, Inc. (GENN) currently holds an AI score of 46/100, indicating low score. Key strength: Extensive network of facilities.. Primary risk to monitor: Potential: Increasing competition from other healthcare providers.. This is not financial advice.
How frequently does GENN data refresh on this page?
GENN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven GENN's recent stock price performance?
Recent price movement in Genesis Healthcare, Inc. (GENN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Extensive network of facilities.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider GENN overvalued or undervalued right now?
Determining whether Genesis Healthcare, Inc. (GENN) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying GENN?
Before investing in Genesis Healthcare, Inc. (GENN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding GENN to a portfolio?
Potential reasons to consider Genesis Healthcare, Inc. (GENN) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Extensive network of facilities.. Additionally: Comprehensive range of services.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of GENN?
Yes, most major brokerages offer fractional shares of Genesis Healthcare, Inc. (GENN) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track GENN's earnings and financial reports?
Genesis Healthcare, Inc. (GENN) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for GENN earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Information is based on available data as of December 31, 2020.
- OTC market data may be limited and less reliable than exchange-listed stocks.
- AI analysis pending for GENN.